PATENT CLAIM ANALYSIS

Application Number: 16090915
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["424", "457000"]

Abstract:
The present invention relates to controlled release pharmaceutical formulations comprising an atypical antipsychotic agent such as Paliperidone in the form of capsule filled with mini-tablets that provide zero order drug release. It also relates to a process for the preparation thereof.

Claim (Index 1):
A controlled release formulation of Paliperidone comprising at least two different distinct units capable of releasing Paliperidone in certain time intervals and at different sites along the gastrointestinal tract in order to achieve zero order drug release profile, wherein the first unit is coated with pH-dependent polymer that dissolves at pH>5.5 and the second unit is coated with pH-dependent polymer that dissolves at pH>7.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 97.0
- Lexical Diversity: 1.13158
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13990861', '15912438', '14238961', '16029239', '16058769']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6823719674915557
- 35 USC 102 Novelty (BERT): 0.4931755974129888
- Combined Prediction Score: 0.6634523304836991
- Mean Citation Score: 164.92661200000003
- Max Citation Score: 166.32453999999996
- Similarity Product: 102.3761999015188

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test